Menu

• Ask a Health Expert about DIFFUSE ALVEOLAR DAMAGE
• Post Your Side Effect related to DIFFUSE ALVEOLAR DAMAGE
• DIFFUSE ALVEOLAR DAMAGE and FDA Warnings
• DIFFUSE ALVEOLAR DAMAGE in Patients Wiki
• Report DIFFUSE ALVEOLAR DAMAGE in Drug Side Effect Survey

DIFFUSE ALVEOLAR DAMAGE side effect

What is DIFFUSE ALVEOLAR DAMAGE ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Erbitux Side Effects Report #5605505-3
Health Professional from FRANCE reported ERBITUX problem on Jan 21, 2008. Male patient, 67 years of age, was diagnosed with squamous cell carcinoma of skin, lung transplant rejection and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: diffuse alveolar damage, respiratory failure, . ERBITUX dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE. Patient died.

Erbitux Side Effects Report #5605574-0
ERBITUX problem was reported by a Health Professional from FRANCE on Jan 21, 2008. Male patient, 59 years of age, was diagnosed with squamous cell carcinoma of skin, immunosuppression and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: diffuse alveolar damage, respiratory failure, . ERBITUX dosage: unknown. During the same period patient was treated with PREDNISONE, MYCOPHENOLATE MOFETIL, SIROLIMUS. Patient was hospitalized. Patient died on 05/01/2006.

Rituxan Side Effects Report #5572235-6
Consumer or non-health professional from UNITED STATES reported RITUXAN problem on Dec 17, 2007. Female patient, 62 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: diffuse alveolar damage, . RITUXAN dosage: unknown. During the same period patient was treated with IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE. Patient was hospitalized. Patient died.

Alimta Side Effects Report #5501711-7
ALIMTA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 26, 2007. Male patient, weighting 175.9 lb, was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: diffuse alveolar damage, emphysema, lung consolidation, lung disorder, lung infiltration, pleural adhesion, pulmonary fibrosis, radiation pneumonitis, silicosis, . ALIMTA dosage: 975 MG. Patient was hospitalized. Patient died on 04/03/2007.


Mercaptopurine Side Effects Report #5442008-3
Health Professional from UNITED STATES reported MERCAPTOPURINE problem on Aug 15, 2007. Male patient, 66 years of age, was diagnosed with crohn's disease and was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: diffuse alveolar damage, interstitial lung disease, myalgia, pulmonary toxicity, respiratory failure, . MERCAPTOPURINE dosage: unknown. During the same period patient was treated with AZATHIOPRINE, PREDNISONE, LANSOPRAZOLE, TAMSULOSIN, ALPRAZOLAM. Patient was hospitalized. Patient recovered.

Fluorouracil Side Effects Report #5387466-8
FLUOROURACIL problem was reported by a Health Professional from KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF on July 03, 2007. Male patient, 75 years of age, was diagnosed with metastatic gastric cancer and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: diffuse alveolar damage, . FLUOROURACIL dosage: unknown. During the same period patient was treated with LEUCOVORIN CALCIUM, OXALIPLATIN. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #5445119-1
Physician from UNITED STATES reported RITUXAN problem on Apr 11, 2007. Female patient, 59 years of age, weighting 224.9 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: diffuse alveolar damage, hypoxia, pneumonitis, . RITUXAN dosage: 800 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with PREDNISONE. Patient was hospitalized. Patient recovered.

Fluorouracil Side Effects Report #5387466-8
FLUOROURACIL problem was reported by a Health Professional from KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF on July 03, 2007. Male patient, 75 years of age, was diagnosed with metastatic gastric cancer and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: diffuse alveolar damage, . FLUOROURACIL dosage: unknown. During the same period patient was treated with LEUCOVORIN CALCIUM, OXALIPLATIN. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #5445119-1
Physician from UNITED STATES reported RITUXAN problem on Apr 11, 2007. Female patient, 59 years of age, weighting 224.9 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: diffuse alveolar damage, hypoxia, pneumonitis, . RITUXAN dosage: 800 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with PREDNISONE. Patient was hospitalized. Patient recovered.


Liquid Side Effects Report #5595456-5
LIQUID BAROSPERSE problem was reported by a Health Professional from FRANCE on Jan 09, 2008. Female patient was diagnosed with barium swallow and was treated with LIQUID BAROSPERSE. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, diffuse alveolar damage, foreign body aspiration, . LIQUID BAROSPERSE dosage: unknown. Patient died.

Xeloda Side Effects Report #5541925-3
Physician from IRELAND reported XELODA problem on Nov 28, 2007. Male patient, 64 years of age, weighting 244.1 lb, was diagnosed with gastric cancer, atrial fibrillation and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, diffuse alveolar damage, neutropenia, pulmonary oedema, pulmonary toxicity, renal failure, septic shock, thrombocytopenia, . XELODA dosage: unknown. During the same period patient was treated with CISPLATIN, EPIRUBICIN, CLEXANE. Patient died on 04/02/2007.

Prednisone Side Effects Report #5500355-0
PREDNISONE problem was reported by a Physician from JAPAN on Oct 10, 2007. Female patient, 62 years of age, was diagnosed with dermatomyositis and was treated with PREDNISONE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, diffuse alveolar damage, interstitial lung disease, . PREDNISONE dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE, CYCLOSPORINE, ORAPRED. Patient died.

Fluorouracil Side Effects Report #5445716-3
Health Professional from UNITED STATES reported FLUOROURACIL problem on Aug 21, 2007. Female patient, 64 years of age, was diagnosed with colon cancer and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, diffuse alveolar damage, eye injury, eye penetration, fall, pulmonary congestion, pulmonary fibrosis, respiratory failure, . FLUOROURACIL dosage: (5600 MG), INTRAVENOUS. During the same period patient was treated with FOLINIC ACID, OXALIPLATIN. Patient was hospitalized. Patient died on 07/15/2007.

Pentasa Side Effects Report #5451852-8
PENTASA problem was reported by a Health Professional from DENMARK on Aug 28, 2007. Male patient, 71 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: cryptogenic organising pneumonia, diffuse alveolar damage, fibrosis, pneumothorax, polyneuropathy, vomiting, . PENTASA dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE, ENALAPRIL MALEATE, SERETIDE. Patient was hospitalized. Patient died on 07/07/2007.


Oxaliplatin Side Effects Report #5393095-2
Consumer or non-health professional from KOREA, REPUBLIC OF reported OXALIPLATIN problem on July 02, 2007. Male patient, 75 years of age, was diagnosed with gastric cancer, metastases to lymph nodes and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: chest x-ray abnormal, diffuse alveolar damage, lung disorder, . OXALIPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, FOLINIC ACID, FOLINIC ACID. Patient recovered.

Prograf Side Effects Report #5401390-3
PROGRAF problem was reported by a Physician from JAPAN on July 10, 2007. Male patient, 62 years of age, was diagnosed with bone marrow transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: bronchopneumonia, diffuse alveolar damage, multi-organ failure, no therapeutic response, sinusitis fungal, . PROGRAF dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE, CYCLOSPORINE. Patient was hospitalized. Patient died.

Oxaliplatin Side Effects Report #5393095-2
Consumer or non-health professional from KOREA, REPUBLIC OF reported OXALIPLATIN problem on July 02, 2007. Male patient, 75 years of age, was diagnosed with gastric cancer, metastases to lymph nodes and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: chest x-ray abnormal, diffuse alveolar damage, lung disorder, . OXALIPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, FOLINIC ACID, FOLINIC ACID. Patient recovered.

Prograf Side Effects Report #5401390-3
PROGRAF problem was reported by a Physician from JAPAN on July 10, 2007. Male patient, 62 years of age, was diagnosed with bone marrow transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: bronchopneumonia, diffuse alveolar damage, multi-organ failure, no therapeutic response, sinusitis fungal, . PROGRAF dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE, CYCLOSPORINE. Patient was hospitalized. Patient died.

Amiodarone Side Effects Report #5738568-5
Consumer or non-health professional from JAPAN reported AMIODARONE problem on Apr 08, 2008. Male patient, 80 years of age, was diagnosed with atrial fibrillation and was treated with AMIODARONE. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, diffuse alveolar damage, lung disorder, pneumonitis, . AMIODARONE dosage: unknown. Patient was hospitalized. Patient died.


Gemzar Side Effects Report #5290310-0
GEMZAR problem was reported by a Physician from FRANCE on Mar 28, 2007. Male patient, 57 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, diffuse alveolar damage, haemoglobin decreased, pulmonary oedema, . GEMZAR dosage: 1000 MG/M2, OTHER. During the same period patient was treated with GLYBURIDE, METFORMIN, LASIX. Patient was hospitalized. Patient died on 01/04/2007.

Albuterol Side Effects Report #5316373-1
Consumer or non-health professional from UNITED STATES reported ALBUTEROL problem on Apr 18, 2007. Female patient, 44 years of age, weighting 189.0 lb, was diagnosed with asthma and was treated with ALBUTEROL. After drug was administered, patient experienced the following problems/side effects: bone disorder, diffuse alveolar damage, fall, fracture, lung disorder, pneumonia, . ALBUTEROL dosage: unknown. During the same period patient was treated with PREDNISONE, OXYGEN. Patient recovered.

Prograf Side Effects Report #5509573-9
PROGRAF problem was reported by a Physician from JAPAN on Oct 24, 2007. Female patient, 70 years of age, weighting 97.00 lb, was diagnosed with rheumatoid arthritis and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, condition aggravated, diffuse alveolar damage, interstitial lung disease, no therapeutic response, rheumatoid lung, . PROGRAF dosage: 1.5 MG, UID/QD, ORAL. During the same period patient was treated with PREDNISOLONE, VOLTAREN, BACACIL, RABEPRAZOLE, ONEALFA, CYTOTEC, FOSAMAC, DIOVAN. Patient died on 08/31/2007.

Methotrexate Side Effects Report #5442687-0
Consumer or non-health professional from reported METHOTREXATE problem on Aug 28, 2007. Male patient, 71 years of age, was diagnosed with rheumatoid arthritis, lymphoma, evidence based treatment and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: angiocentric lymphoma, axillary mass, diffuse alveolar damage, interstitial lung disease, lymphoproliferative disorder, . METHOTREXATE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, METHYLPREDNISOLONE, PANIPENEM, FLUCONAZOLE, SULFAMETHOXAZOLE. Patient was hospitalized. Patient died on 08/05/2002.

Decadron Side Effects Report #5453538-2
DECADRON problem was reported by a Health Professional from UNITED STATES on Sept 05, 2007. Male patient, 51 years of age, was diagnosed with non-small cell lung cancer and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: agitation, bacteraemia, diffuse alveolar damage, duodenal ulcer perforation, fluid overload, hypotension, interstitial lung disease, klebsiella infection, . DECADRON dosage: 20 MG/PO, 128 MG/DAILY/PO. During the same period patient was treated with CETUXIMAB, DOCETAXEL, GEMCITABINE, ALLEGRA D. Patient was hospitalized. Patient died on 08/19/2007.

Alemtuzumab Side Effects Report #5474809-X
Physician from UNITED STATES reported ALEMTUZUMAB problem on Sept 27, 2007. Female patient, weighting 97.00 lb, was treated with ALEMTUZUMAB. After drug was administered, patient experienced the following problems/side effects: blood triglycerides increased, chondrocalcinosis pyrophosphate, diffuse alveolar damage, encephalitis, febrile neutropenia, histiocytosis haematophagic, hypotension, intra-abdominal haemorrhage, . ALEMTUZUMAB dosage: 30MG EVERY 3 WEEKS IV DRIP. During the same period patient was treated with ETOPOSIDE, ONCOVIN, HYDROXYLDAUNORUBICIN, CYCLOPHOSPHAMIDE, PREDNISONE, NEUPOGEN, PENTAMIDINE ISETHIONATE, ACYCLOVIR. Patient died on 05/10/2007.

Gemzar Side Effects Report #5430548-2
GEMZAR problem was reported by a Physician from JAPAN on Aug 27, 2007. Female patient, 53 years of age, was diagnosed with lung adenocarcinoma stage ii and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, continuous haemodiafiltration, diffuse alveolar damage, gastrointestinal haemorrhage, hepatic failure, interstitial lung disease, lung infiltration, multi-organ failure, . GEMZAR dosage: unknown. Patient was hospitalized. Patient died on 08/23/2006.

Fluorouracil Side Effects Report #5443611-7
Consumer or non-health professional from UNITED STATES reported FLUOROURACIL problem on Aug 15, 2007. Male patient, 64 years of age, was diagnosed with colon cancer and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, colon cancer metastatic, diffuse alveolar damage, dyspnoea, eye injury, eye penetration, fall, pneumonia, pulmonary fibrosis, . FLUOROURACIL dosage: 5600 MILLIGRAM IV. During the same period patient was treated with LEUCOVORIN CALCIUM, OXALIPLATIN. Patient was hospitalized. Patient died.

Cubicin Side Effects Report #5729906-8
CUBICIN problem was reported by a Physician from UNITED STATES on Apr 16, 2008. Male patient, 63 years of age, weighting 218.9 lb, was diagnosed with bacterial infection, catheter related infection and was treated with CUBICIN. After drug was administered, patient experienced the following problems/side effects: blood culture positive, catheter related infection, diffuse alveolar damage, interstitial lung disease, neuropathy peripheral, . CUBICIN dosage: 5 MG/KG; Q24H; IV. During the same period patient was treated with LEVAQUIN, LISINOPRIL, PLAVIX, TOPROL, ZOCOR. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5713731-8
Physician from UNITED STATES reported REVLIMID problem on Apr 11, 2008. Male patient, 66 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, cardiac failure congestive, diffuse alveolar damage, infection, injury, pneumonia, pulmonary oedema, respiratory failure, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL; 25 MG, 1 IN 1 D, ORAL. Patient was hospitalized and became disabled. Patient died on 03/24/2008.

Neoral Side Effects Report #5352189-8
NEORAL problem was reported by a Consumer or non-health professional from JAPAN on June 05, 2007. Male patient, 62 years of age, was diagnosed with stem cell transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease, diarrhoea, diffuse alveolar damage, headache, immunodeficiency, mass, multi-organ failure, nodule, olfactory nerve disorder, . NEORAL dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE, TACROLIMUS, RITUXAN, CYCLOPHOSPHAMIDE, NOVANTRONE, ONCOVIN, PREDNISONE. Patient was hospitalized. Patient died.

Neoral Side Effects Report #5353467-9
Consumer or non-health professional from JAPAN reported NEORAL problem on June 05, 2007. Male patient, 62 years of age, was diagnosed with stem cell transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease, diarrhoea, diffuse alveolar damage, headache, immunodeficiency, mass, multi-organ failure, nodule, olfactory nerve disorder, . NEORAL dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE, TACROLIMUS, RITUXAN, CYCLOPHOSPHAMIDE, NOVANTRONE, ONCOVIN, PREDNISONE. Patient was hospitalized. Patient died.

Cyclophosphamide Side Effects Report #5293592-4
CYCLOPHOSPHAMIDE problem was reported by a Health Professional from UNITED STATES on Apr 09, 2007. Female patient, 73 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cardiac failure, deep vein thrombosis, diffuse alveolar damage, enterococcal infection, interstitial lung disease, lung infection pseudomonal, multi-organ failure, pneumomediastinum, pneumothorax, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with AMIODARONE, RITUXIMAB. Patient was hospitalized. Patient died.

Tacrolimus Side Effects Report #5266625-9
Physician from JAPAN reported TACROLIMUS CAPSULES problem on Feb 27, 2007. Female patient, 74 years of age, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS CAPSULES. After drug was administered, patient experienced the following problems/side effects: blood pressure systolic increased, condition aggravated, diffuse alveolar damage, fungal infection, heart rate increased, interstitial lung disease, lung disorder, no therapeutic response, pneumocystis jiroveci infection, . TACROLIMUS CAPSULES dosage: unknown. During the same period patient was treated with TACROLIMUS CAPSULES, METALCAPTASE CAPSULE, PREDNISOLONE, LOXONIN, CLINORIL, MUCOSTA, AMARYL. Patient died on 08/13/2006.